Seyfarth Shaw – Blog Post
The FDA believes that scientifically valid research conducted under an investigational new drug (IND) application is the best way to determine which patients could benefit from the use of drugs derived from marijuana. According to the FDA’s website, the FDA supports the conduct of that research by:
- Providing information on the process needed to conduct clinical research using marijuana;
- Providing information on the specific requirements needed to develop a drug that is derived from a plant such as marijuana. In June 2004, the FDA finalized its Guidance for Industry: Botanical Drug Products, which provides sponsors with guidance on submitting IND applications for botanical drug products;
- Providing specific support for investigators interested in conducting clinical research using marijuana and its constituents as a part of the IND process through meetings and regular interactions throughout the drug development process;
- Providing general support to investigators to help them understand and follow the procedures to conduct clinical research through the FDA Center for Drug Evaluation and Research’s Small Business and Industry Assistance group.
More at link above
The Cannabist: With DEA digging in its heels on “marijuana extracts,” legality of CBD oil on trial in federal courts Cannabist Special Report: CBD, TBD || Outcome of lawsuit pitting the hemp industry against the DEA could chart a new course for CBD — and a booming new agricultural sector.
A federal lawsuit filed in January by Denver’s Hoban Law Group on behalf of the Hemp Industries Association, Centuria Natural Foods and RMH Holdings LLC was intended to protect an American agricultural revival, attorney Bob Hoban told The Cannabist.
“The entire industry hinges on this,” Hoban said.
Now it’s up to the 9th U.S. Circuit Court of Appeals to make a decision that could chart a new course for the hemp industry.
More at link above.
Council adds medical pot restrictions Ban in multi-family housing in San Mateo follows law legalizing recreational marijuana
Following the passage of Proposition 64, the San Mateo City Council voted last month to update its stringent smoking ban to include medicinal marijuana in multi-family residences. Whether you rent or own, if you share walls and ventilation equipment with your neighbors the city will soon prohibit people from smoking or vaporizing marijuana — even if it’s prescribed by a doctor.
City councilmembers hailed their unanimous vote as a way to protect the public against unwanted secondhand smoke, noting the city and police department have received numerous complaints from residents of multi-family buildings.
Minnesota medical cannabis program to include PTSD
Minnesotans who suffer from post-traumatic stress disorders will be eligible to try medical cannabis starting Aug. 1.
To receive the drug through the program, patients need to visit a health care professional who must then certify to the Minnesota Department of Health that the patients suffer from the condition. Once certified, patients can then register on the state health department’s website. Registration for PTSD started July 1.
‘Political Insiders’ say medical marijuana ballot initiative will not pass in 2018
55% of the Republicans who answered our survey said the initiative would not pass.
61% of the Democrats who responded said the medical marijuana initiative would fail at the ballot box.
However, 77% of our readers say it will pass.
More at link above